tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IPSC Stock Latest News

Century Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
The FlyCentury Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
3d ago
IPSC
Century Therapeutics price target lowered to $7 from $11 at Chardan
PremiumThe Fly
Century Therapeutics price target lowered to $7 from $11 at Chardan
13d ago
IPSC
Century Therapeutics price target lowered to $5 from $12 at Guggenheim
PremiumThe Fly
Century Therapeutics price target lowered to $5 from $12 at Guggenheim
16d ago
IPSC
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
PremiumCompany Announcements
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
16d ago
IPSC
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
PremiumThe Fly
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
17d ago
IPSC
Century Therapeutics Re-prioritizes Pipeline for Key Programs
PremiumCompany AnnouncementsCentury Therapeutics Re-prioritizes Pipeline for Key Programs
17d ago
8K
IPSC
Century Therapeutics trading resumes
Premium
The Fly
Century Therapeutics trading resumes
17d ago
IPSC
Century Therapeutics trading halted, news pending
Premium
The Fly
Century Therapeutics trading halted, news pending
17d ago
IPSC
Century announces investigator-initiated Phase 1/2 trial of CNTY-101
PremiumThe Fly
Century announces investigator-initiated Phase 1/2 trial of CNTY-101
2M ago
IPSC
Century Therapeutics Unveils Advances in Cell Therapies
PremiumCompany Announcements
Century Therapeutics Unveils Advances in Cell Therapies
3M ago
8K
IPSC
Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
PremiumThe Fly
Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
3M ago
BMY
IPSC
Century Therapeutics Faces Termination of BMS Agreement
PremiumCompany Announcements
Century Therapeutics Faces Termination of BMS Agreement
4M ago
8K
IPSC
Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults
PremiumCompany AnnouncementsCentury Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults
5M ago
IPSC
Century Therapeutics price target lowered to $11 from $17 at Chardan
Premium
The Fly
Century Therapeutics price target lowered to $11 from $17 at Chardan
5M ago
IPSC
Century Therapeutics price target lowered to $5 from $9 at H.C. Wainwright
Premium
The Fly
Century Therapeutics price target lowered to $5 from $9 at H.C. Wainwright
5M ago
IPSC
Century Therapeutics Reports Q3 Results & Strategic Updates
PremiumCompany Announcements
Century Therapeutics Reports Q3 Results & Strategic Updates
5M ago
IPSC
Century Therapeutics reports Q3 EPS (37c), consensus (45c)
PremiumThe Fly
Century Therapeutics reports Q3 EPS (37c), consensus (45c)
5M ago
IPSC
Century Therapeutics expects cash to support operations into 2H26
PremiumThe Fly
Century Therapeutics expects cash to support operations into 2H26
5M ago
IPSC
Century Therapeutics sees FY24 GAAP operating expenses $150M-$160M
PremiumThe Fly
Century Therapeutics sees FY24 GAAP operating expenses $150M-$160M
5M ago
IPSC
Century Therapeutics Appoints Morgan Conn as New CFO
PremiumCompany AnnouncementsCentury Therapeutics Appoints Morgan Conn as New CFO
6M ago
8K
IPSC
Century Therapeutics appoints Conn as CFO, Cowan as CSO
Premium
The Fly
Century Therapeutics appoints Conn as CFO, Cowan as CSO
6M ago
IPSC
Century Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
Premium
The Fly
Century Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
8M ago
IPSC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >